After the recent discovery of two DNA markers responsible for autism, the Autism Genome Project has announced that the international research to pinpoint the genetic origin of the condition will carry on to identify further genes implicated in this disorder. Further research means renewed hope for the sufferers and their families.

Phase Two of the Autism Genome Project was also announced to continue the effort to discover the genes that cause the disorder. This second phase represents a $14.5 million, three-year investment by Autism Speaks, the British Medical Research Council, the Health Research Board of Ireland, Genome Canada and its partners, Canadian Institutes for Health Research, Southwest Autism Research and Resource Center, and the Hilibrand Foundation.

Source: Science Daily